Thermal Potentiation of Cancer Treatment Shows Promising but Limited Results

Strategic Insights -

Research conducted by the University of Oslo has yielded mixed results regarding the potential of thermal potentiation to enhance the effectiveness of cancer treatments. The study, which was published in the BMC Research Notes journal, aimed to investigate the relationship between body temperature and cancer resistance. The findings suggest that febrile temperature can improve cancer resistance, but the cytotoxic T cells, which are responsible for killing cancer cells, do not display an improved ability to do so.

Key Takeaways:

  • The study found that febrile temperature is associated with improved cancer resistance, with the cytotoxic T cells being linked to this improved resistance.
  • In murine models, the research showed that the differentiation of cytotoxic T cells into cancer-killing effector cells is poor at lower temperatures but robust at elevated temperatures.
  • The study tested the potential of thermal potentiation to improve the effectiveness of chimeric antigen receptor T-cell therapy (CAR T-cell therapy) in humans, but the results were inconclusive.
  • The researchers observed elevated levels of IFN-g in human CAR-T cells exposed to febrile temperature, but the cells' ability to kill cancer cells remained unaffected.
  • The study concluded that incorporating thermal potentiation into existing cancer treatments, including CAR T-cell therapy, may be more complicated than anticipated.

Statistics:

  • The study was conducted by researchers from the Department of Biosciences at the University of Oslo, led by Niladri Bhusan Pati.
  • The research involved the use of murine models to investigate the effects of febrile temperature on cancer resistance.
  • The study found that transient exposure to febrile temperature (39-40 ºC) increases the production of IFN-g by 25% in mice.
  • The research also observed elevated levels of IFN-g (30%) in human CAR-T cells exposed to febrile temperature.
  • The study found that the cytotoxic ability of human CAR-T cells remained unaffected by thermal potentiation.

Sources:

  • BMC Research Notes, 2025,18(1):1-7 (https://doi-org.sdpl.idm.oclc.org/10.1186/s13104-025-07249-5)
  • Niladri Bhusan Pati, Department of Biosciences, University of Oslo
  • Yixin Jin, Suman Kumar, Jon Amund Kyte, Rafal Ciosk, Department of Biosciences, University of Oslo.